Cyfluthrin


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D001259 Ataxia PMID:26604153
MESH:D006402 Hematologic Diseases PMID:35126122
MESH:D006529 Hepatomegaly PMID:35126122
MESH:D007035 Hypothermia PMID:19748519
MESH:D007249 Inflammation PMID:36515635
MESH:D007794 Lameness, Animal PMID:19748519
MESH:D008569 Memory Disorders PMID:26604153
MESH:D010922 Placenta Diseases PMID:36548566
MESH:D011041 Poisoning PMID:28456311; PMID:28742096; PMID:32203733
MESH:D012135 Respiratory Sounds PMID:27384423
MESH:D012640 Seizures PMID:19748519
MESH:D013733 Testicular Diseases PMID:36515635
MESH:D014202 Tremor PMID:19748519
MESH:D015431 Weight Loss PMID:35126122
MESH:D018476 Hypokinesia PMID:20019907
MESH:D020258 Neurotoxicity Syndromes PMID:19766671
MESH:D020567 Fetal Weight PMID:36548566
MESH:D020879 Neuromuscular Manifestations PMID:19748519
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:23595963

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.